Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Inmune Bio (INMB) has issued an announcement.
INmune Bio Inc. has recently granted their CEO, Ramond J. Tesi, an option to buy 37,882 shares at $8.72 each as part of their 2021 Stock Incentive Plan. This option became effective immediately and is set to expire on June 9, 2034, demonstrating the company’s confidence in their leadership and providing an incentive for continued success.
For detailed information about INMB stock, go to TipRanks’ Stock Analysis page.
